ELUT
ELUTIA INC.
Key Financials
Net Income
$53.4M
↑ 198.9%
Gross Profit
$6.6M
↓ 38.4%
Operating Income
$-26911000
↑ 24.5%
Cash & Equivalents
$36.4M
↑ 174.6%
Total Liabilities
$34.7M
↓ 57.9%
Total Assets
$62.4M
↑ 72.6%
Shareholders' Equity
$27.7M
↑ 159.8%
EPS (Diluted)
$0.87
↑ 146.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| S-8 | 8/14/2026 | View on SEC |
| 10-Q | 8/14/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 8-K | 8/13/2026 | View on SEC |
| SCHEDULE 13G | 8/11/2026 | View on SEC |
| 8-K | 8/7/2026 | View on SEC |
| 8-K | 7/20/2026 | View on SEC |
| 4 | 6/22/2026 | View on SEC |
| 8-K | 6/16/2026 | View on SEC |
| 4 | 6/15/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ELUT |
| Company Name | ELUTIA INC. |
| CIK | 1708527 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 240-247-1143 |